🇺🇸 FDA
Patent

US 11203749

Factor VII polypeptides that are modified and uses thereof

granted A61KA61K38/00A61K48/00

Quick answer

US patent 11203749 (Factor VII polypeptides that are modified and uses thereof) held by Catalyst Biosciences, Inc. expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Dec 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P7/04